Everything on Pharmaceutical Competition

Novo Nordisk's patent lawsuit against Hims & Hers marks a decisive legal escalation in the GLP-1 drug market, targeting the broader compound rather than just specific products.

Impact: This legal battle could significantly impact Hims' business model and market positioning, while reinforcing Novo's intellectual property rights and market dominance in the weight-loss drug sector.

— from GM Battery Bet, Kroger Leadership, and Market M&A Trends · OHNE AKTIEN WIRD SCHWER - Tägliche Börsen-News· Feb 10, 2026